Medicare Enrolled

Dr. Olatunde Osofisan, DPM

Sports Medicine Podiatrist · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
1545 ATLANTIC AVE, Brooklyn, NY 11213
7186137005
In practice since 2011 (14 years)
NPI: 1306129341 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Osofisan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Osofisan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Osofisan

Dr. Olatunde Osofisan is a sports medicine podiatrist in Brooklyn, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Osofisan performed 728 Medicare services across 393 unique beneficiaries.

Between the years covered by Open Payments, Dr. Osofisan received a total of $100,020 from 48 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine podiatrist. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Osofisan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 728 Medicare services $100,020 industry payments

Medicare Practice Summary

Medicare Utilization ↗
728
Medicare services
Bottom 25% in NY for sports medicine podiatrist
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
393
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~52 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
261 $80 $273
Toenail/fingernail removal, 6+ nails
Surgical removal of six or more fingernails or toenails. This procedure involves the excision of multiple nails during a single session.
138 $41 $242
Skin and tissue removal, 20 sq cm or less
This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller.
125 $43 $762
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
106 $103 $399
Removal of thickened skin growths, 2-4
This procedure involves the removal of two to four benign, thickened skin growths. It is a minor surgical intervention to eliminate non-cancerous skin lesions.
75 $78 $584
Trimming of dystrophic nails
Trimming of dystrophic nails, any number
23 $21 $186
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$100,020
Total received (2018-2024)
Avg $14,289/year across 7 years
Top 0% in NY for sports medicine podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$55,590 (55.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$44,119 (44.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,215
2023
$7,412
2022
$11,822
2021
$21,267
2020
$17,259
2019
$30,781
2018
$5,266

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$1,671
MIMEDX Group, Inc.
$1,215
Linvatec Corporation
$947
Abbott Laboratories
$812
TREACE MEDICAL CONCEPTS, INC.
$445
ShockWave Medical, Inc
$286
Nevro Corp.
$283
Medtronic, Inc.
$147
PolyNovo North America LLC
$146
Orthofix Medical, Inc.
$77
Aroa Biosurgery Incorporated
$61
Paratek Pharmaceuticals, Inc.
$42
Averitas Pharma Inc.
$37
Organogenesis Inc.
$23
VERTEX PHARMACEUTICALS INCORPORATED
$23
Top 3 companies account for 61.7% of 2024 payments
All-time payments by company (2018-2024) ›
Royal Biologics
$39,595
Stryker Corporation
$16,993
Royal Biologics, Inc.
$13,497
Cardiovascular Systems Inc.
$5,746
Novastep Inc.
$4,592
Trilliant Surgical LLC.
$2,799
Abbott Laboratories
$2,079
Integra LifeSciences Corporation
$1,897
Smith+Nephew, Inc.
$1,263
MIMEDX Group, Inc.
$1,215
WRIGHT MEDICAL TECHNOLOGY, INC.
$1,174
Linvatec Corporation
$1,149
TREACE MEDICAL CONCEPTS, INC.
$980
Wright Medical Technology, Inc.
$834
In2Bones USA, LLC
$800
Vilex LLC
$800
Nevro Corp.
$606
Paratek Pharmaceuticals, Inc.
$400
Osteomed LLC
$361
Organogenesis Inc.
$344
ShockWave Medical, Inc
$286
ORGANOGENESIS INC.
$220
AbbVie Inc.
$200
Acera Surgical, Inc.
$194
Smith & Nephew, Inc.
$181
ACUMED LLC
$180
ENCORE MEDICAL, LP
$179
Osiris Therapeutics Inc.
$165
Kerecis Limited
$155
MedShape, Inc.
$154
Medtronic, Inc.
$147
PolyNovo North America LLC
$146
PFIZER INC.
$120
Shockwave Medical, Inc
$106
Orthofix Medical, Inc.
$77
Paragon 28, Inc.
$66
Aroa Biosurgery Incorporated
$61
KCI USA, Inc.
$43
Averitas Pharma Inc.
$37
Horizon Therapeutics plc
$36
GlaxoSmithKline, LLC.
$24
VERTEX PHARMACEUTICALS INCORPORATED
$23
DJO, LLC
$18
DePuy Synthes Sales Inc.
$17
ConvaTec Inc.
$16
KCI USA, Inc
$16
Derma Sciences, Inc.
$16
SANOFI PASTEUR INC.
$14
Top 3 companies account for 70.1% of all-time payments
Associated products mentioned in payments ›
7 X 23MM CITRELOCK IMPLANT · ACTISHIELD · ACTISHIELD CF · ACTIV.A.C. · ACUMED · AIRLOCK Forefoot/Midfoot Plating · ALLOGRAFT · ALLOGRAFT BIO-IMPLANTS · ALLOWRAP · AM · AMNIO MAXX · ANCHORAGE · AQUACEL AG · ARCAD Nitinol Compression Staples · ASNIS · AUGMENT INJECTABLE · AVEIR · AXSOS · Allure Quadra RF CRT Pacemaker · Amnio Maxx · AmnioMaxx · Apligraf · Arsenal · Arsenal Ankle 10 Hole 1/3 Tubular Plate · Arsenal Sinus Support Plate · BEXSERO · BILAYER WOUND MATRIX (BWM) · BILAYER WOUND MATRIX BWM · BIOBRACE 23MM · BIOFIX · BIOFOAM · CADENCE ANKLE REPLACEMENT SYSTEM · CARTIVA · CARTIVA SYNTHETIC CARTILAGE IMPLANT · CHARLOTTE · CITREFIX · CLAW II · CLOSUREFAST · COLLAGENASE SANTYL · COROFLOW · CoLink · Cryo-Cord · CryoCord · Cryocord · DALVANCE · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · DUEXIS · Diamondback Peripheral · DynaNail · EASY CLIP · EASYFUSE · EUCRISA · EVOS SMALL · EXT-Encompass · EXT-ExtremiLock Ankle · EXT-Subtalar · FIBRINET · FRACTURE AND CORRECTION COLAG 2 · FUSIONFRAME Ring Lock Circular Fixator · Fibrinet · GALLANT · GRAFIX PL · GRAFTJACKET · GRAVITY · GRAVITY SYNCHFIX · HOFFMANN · Kerecis Omega3 SurgiClose · LAPIPLASTY SYSTEM · LINVATEC EXTREMITIES · MENQUADFI · MICRO · MIS Instrumentation · Maxx Ultra Cord · Maxx-Ultra Cord · MaxxCell · NEURAGEN · NOVOSORB BTM · NUZYRA · ORTHOLOC · ORTHOLOC 2 LAPIFUSE · ORTHOLOC 3DI · Omnia · PECA Bunion Correction System · PECA-C Compressive Implants · PHALINX · PREVENA · PROLAYER · PROPHECY · PROSTEP · PROSTEP MICA · Panta 2 · Peripheral Orbital Atherectomy System · Physio-Stim · Puraply · Puraply Antimicrobial · QUTENZA · Quadra Assura CRT Defibrillator · REGRANEX · Regranex · Restrata Wound Matrix · Royal Biologics · SALTO TALARIS TOTAL ANKLE PROSTHESIS · SALVATION · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SIDEKICK · SMART TOE · SONICANCHOR · SONICFUSION · SONICPIN · Santyl · Senza · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stravix · T2 · TENFUSE · UNIVERSAL MANDIBLE · VA-LCP PLATES & SCREWS · VALOR · VARIAX · VITOSS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for sports medicine podiatrist in NY.

Looking for a sports medicine podiatrist in Brooklyn?
Compare sports medicine podiatrists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse sports medicine podiatrists nearby

Geographic Context

Sports medicine podiatrists within 10 mi
12
Per 100K population
0.5
County median income
$78,548
Nearest hospital
BROOKDALE HOSPITAL MEDICAL CENTER
1.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Osofisan is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 0% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Osofisan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Osofisan performed 261 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Osofisan receive payments from pharmaceutical companies?
Yes. Dr. Osofisan received a total of $100,020 from 48 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Osofisan's costs compare to other sports medicine podiatrists in Brooklyn?
Dr. Osofisan's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Osofisan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →